- Tumor pyruvate kinase M2 modulators: a comprehensive account of activators and inhibitors as anticancer agents
Bhagyashri Rathod et al, 2021, RSC Medicinal Chemistry CrossRef - Proton pump inhibitors enhance chemosensitivity, promote apoptosis, and suppress migration of breast cancer cells
Worood G. Ihraiz et al, 2020, Acta Pharmaceutica CrossRef - Drug Repurposing in Gastric Cancer: Current Status and Future Perspectives
Marina Leite et al, 2023, Hereditary Gastric and Breast Cancer Syndrome CrossRef - PKM2–c-Myc–Survivin Cascade Regulates the Cell Proliferation, Migration, and Tamoxifen Resistance in Breast Cancer
Pian Yu et al, 2020, Frontiers in Pharmacology CrossRef - Comparative randomized trial evaluating the effect of proton pump inhibitor versus histamine 2 receptor antagonist as an adjuvant therapy in diffuse large B-cell lymphoma
Sahar K. Hegazy et al, 2021, Medical Oncology CrossRef - Expression and Transcriptional Regulation of Human ATP6V1A Gene in Gastric Cancers
Pin Wang et al, 2017, Scientific Reports CrossRef - Repositioning of proton pump inhibitors in cancer therapy
Zhen-Ning Lu et al, 2017, Cancer Chemotherapy and Pharmacology CrossRef - Identification of Gliotoxin isolated from marine fungus as a new pyruvate kinase M2 inhibitor
Wei Tang et al, 2020, Biochemical and Biophysical Research Communications CrossRef - Strategies to Target Glucose Metabolism in Tumor Microenvironment on Cancer by Flavonoids
Gang Wang et al, 2017, Nutrition and Cancer CrossRef - A Review of the Novel Application and Potential Adverse Effects of Proton Pump Inhibitors
Li-Yuan Yu et al, 2017, Advances in Therapy CrossRef - A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2
Sahil Arora et al, 2022, Journal of Medicinal Chemistry CrossRef - Association between Proton Pump Inhibitor Use and the Risk of Female Cancers: A Nested Case-Control Study of 23 Million Individuals
Nhi Thi Hong Nguyen et al, 2022, Cancers CrossRef - MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in cervical cancer
Man Guo et al, 2017, Oncotarget CrossRef - BAPST. A Combo of Common Use Drugs as Metabolic Therapy for Cancer: A Theoretical Proposal
Adriana Romo-Perez et al, 2022, Current Molecular Pharmacology CrossRef - Proposal to Consider Chemical/Physical Microenvironment as a New Therapeutic Off-Target Approach
Alessandro Giuliani et al, 2022, Pharmaceutics CrossRef - Proton pump inhibition and cancer therapeutics: A specific tumor targeting or it is a phenomenon secondary to a systemic buffering?
Enrico Spugnini et al, 2017, Seminars in Cancer Biology CrossRef - Cancer metabolism control by natural products: Pyruvate kinase M2 targeting therapeutics
Ali H. El‐Far et al, 2022, Phytotherapy Research CrossRef - Pantoprazole pretreatment elevates sensitivity to vincristine in drug-resistant oral epidermoid carcinoma in vitro and in vivo
Zhen-Ning Lu et al, 2019, Biomedicine & Pharmacotherapy CrossRef - Coptis chinensis and dried ginger herb combination inhibits gastric tumor growth by interfering with glucose metabolism via LDHA and SLC2A1
Min Fu et al, 2022, Journal of Ethnopharmacology CrossRef - Rethinking the Combination of Proton Exchanger Inhibitors in Cancer Therapy
Elisabetta Iessi et al, 2017, Metabolites CrossRef - Negative Association of Proton Pump Inhibitors With Subsequent Development of Breast Cancer: A Nationwide Population‐Based Study
Chao‐Hung Chen et al, 2019, The Journal of Clinical Pharmacology CrossRef